Evidence for low-density lipoprotein-induced expression of connective tissue growth factor in mesangial cells

Kidney International

Volumn 67, Issue 4, 2005, Pages 1286-1296

  Sohn, Mimi ^b   Tan, Yan ^b   Klein, Richard L ^b   Jaffa, Ayad A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NONE

Author keywords

Collagen I; JNK; MAPK; TGF

Indexed keywords

COLLAGEN TYPE 1; CONNECTIVE TISSUE GROWTH FACTOR; LOW DENSITY LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUTRALIZING ANTIBODY; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ANTIBODY;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE COURSE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; GLOMERULOPATHY; HYPERLIPIDEMIA; KIDNEY FIBROSIS; KIDNEY INJURY; LIPOPROTEIN BLOOD LEVEL; MESANGIUM CELL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; RAT; REGULATORY MECHANISM; RISK FACTOR; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

EID: 16244381722     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00206.x     Document Type: Article

References (48)

1. UNITED STATES RENAL DATA SYSTEM (USRDS): 2000 Annual Data Report, Bethesda, MD, National Institutes of Health
2. MAUER M, DRUMMOND K, FOR THE INTERNATIONAL DIABETIC NEPHROPATHY STUDY GROUP: The early natural history of nephropathy in type 1 diabetes: Study design and baseline characteristics of the study participants. Diabetes 51:1572-1579, 2002
3. DRUMMOND K, MAUER M, FOR THE INTERNATIONAL DIABETIC NEPHROPATHY STUDY GROUP: The early natural history of nephropathy in type 1 diabetes: Early renal structural changes in type 1 diabetes. Diabetes 51:1580-1587, 2002
4. THE DIABETES CONTROL AND COMPLICATIONS (DCCT) RESEARCH STUDY GROUP: Effect of intensive therapy on the development and progression of diabetic nephropathy in the diabetes control and complications trial. Kidney Int 47:1703-1720, 1995
5. SHARMA K, ZIYADEH FN: The emerging role of transforming growth factor-β in kidney disease. Am J Physiol 35:F829-F842, 1994
6. DUNCAN MR, FRAZIER KS, ABRAMSON S, et al: Connective tissue growth factor mediates transforming growth factor-beta-induced collagen synthesis: Down regulation by cAMP. FASEB J 13:1774-1786, 1999
7. BRADHAM DM, IGARASHI A, POTTER RL, et al: Connective tissue growth factor: A cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 114:1285-1294, 1991
8. BORK P: The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS 327:125-130, 1993
9. ITO Y, ATEN J, BENDE RJ, et al: Expression of connective tissue growth factor in renal fibrosis. Kidney Int 53:853-861, 1998
10. GORE-HYER E, SHEGOGUE D, MARKIEWICZ M, et al: TGF-β and CTGF have overlapping and distinct fibrogenic effects on human renal cells. Am J Physiol 283:F707-F716, 2002
11. LAAKSO M, PYORALA K: Lipid and lipoprotein abnormalities in diabetic patients with peripheral vascular disease. Atherosclerosis 74:55-63, 1988
12. LOPES-VIRELLA MF, WOHLTMANN HJ, MAYFIELD RK, et al: Effect of metabolic control on lipid, lipoprotein and apolipoprotein levels in 55 insulin-dependent diabetic patients: A longitudinal study. Diabetes 32:20, 1983
13. SOSENKO JM, BRESLOW JL, MIETTINEN OS, et al: Hyperglycemia and plasma lipid levels: A prospective study of young insulin-dependent diabetic patients. N Engl J Med 302:650, 1980
14. JOVEN J, VILELLA E, COSTA B, et al: Concentrations of lipids and apolipoproteins in patients with clinically well-controlled insulin-dependent and non-insulin-dependent diabetes. Clin Chem 35:813-816, 1989
15. MOORHEAD JF, CHAN MK, EL-NAHAS M, et al: Lipid nephrotoxicity in chronic progressive glomerular and tubulointerstitial disease. Lancet 11:1309-1311, 1982
16. KEANE WF, KASISKE BL, O'DONNELL MP: Lipids and progressive glomerulosclerosis: A model analogous to atherosclerosis. Am J Nephrol 8:261-271, 1988
17. KAMANNA VS: Low density lipoproteins and mitogenic signal transduction processes: Role in the pathogenesis of renal disease. Histol Histopathol 17:497-505, 2002
18. ENG E, FLOEGE J, YOUNG BA, et al: Does extracellular matrix expansion in glomerular disease require mesangial cell proliferation? Kidney Int (Suppl 45):S45-S47, 1994
19. LEE HS, KIM BC, HONG HK, et al: LDL stimulates collagen mRNA synthesis in mesangial cells through induction of PKC and TGF-beta expression. Am J Physiol 277:F369-F376, 1999
20. STUDER RK, CRAVEN PA, DERUBERTIS FR: Low-density lipoprotein stimulation of mesangial cell fibronectin synthesis: Role of protein kinase C and transforming growth factor-beta. J Lab Clin Med 125:86-95, 1995
21. LOVETT DH, STERZEL RB, KASHGARIAN M, et al: Proteinase activity produced in vitro by cells of glomerular mesangium. Kidney Int 23:342-349, 1983
22. JENKINS AJ, VELARDE V, KLEIN RL, et al: Native and modified LDL activate extracellular signal-regulated kinases in mesangial cells. Diabetes 49:2160-2169, 2000
23. DOUILLET CD, VELARDE V, CHRISTOPHER JT, et al: Mechanisms by which bradykinin promotes fibrosis in vascular smooth muscle cells: Role of TGF-β and MAPK. Am J Physiol 279:H2829-H2837, 2000
24. JOVEN J, VILELLA E, COSTA B, et al: Concentrations of lipids and apolipoproteins in patients with clinically well-controlled insulin-dependent and on-insulin-dependent diabetes. Clin Chem 35:813-816, 1989
25. SEMENKOVICH CF, OSTLUND RE JR., SCHECHTMAN KB: Plasma lipids in patients with type I diabetes mellitus: Influence of race, gender and plasma glucose control: Lipids do not correlate with glucose control in black women. Arch Intern Med 149:51-56, 1989
26. ORCHARD TJ, CHANG YF, FERRELL RE, et al: Nephropathy in type 1 diabetes: A manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the EDC Study. Kidney Int 62:963-970, 2002
27. JENKINS AJ, LYONS TJ, ZHENG D, et al: Lipoproteins in the DCCT/EDIC cohort: Association with diabetic nephropathy. Kidney Int 64:817-828, 2003
28. PERKINS BA, FICOCIELLO LH, SIVA KH, et al: Regression of microalbuminuria in type 1 diabetes. N Engl J Med 348:2285-2293, 2003
29. THE DIABETES CONTROL AND COMPLICATIONS TRIAL/EPIDEMIOLOGY OF DIABETES INTERVENTIONS AND COMPLICATIONS RESEARCH GROUP: Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med 348:2294-2303, 2003
30. LEASK A, HOLMES A, ABRAHAM DJ: Connective tissue growth factor: A new and important player in the pathogenesis of fibrosis. Curr Rheumatol Rep 4:136-142, 2002
31. RISER BL, DENICHILO M, CORTES P, et al: Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. J Am Soc Nephrol 11:25-38, 2000
32. RISER BL, CORTES P: Connective tissue growth factor and its regulation: A new element in diabetic glomerulosclerosis. Ren Fail 23:459-470, 2001
33. WAHAB NA, YEVDOKIMOVA N, WESTON BS, et al: Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy. Blochem J 359:77-87, 2001
34. GOLDSCHMEDING R, ATEN J, ITO Y, et al: Connective tissue growth factor: just another factor in renal fibrosis? Nephrol Dial Transplant 15:296-299, 2000
35. CREAN JK, FINLAY D, MURPHY M, et al: The role of p42/44 MAPK and protein kinase B in connective tissue growth factor induced extracellular matrix protein production, cell migration, and actin cytoskeletal rearrangement in human mesangial cells. J Biol Chem 277:44187-44194, 2002
36. MURPHY M, GODSON C, CANNON S, et al: Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem 274:5830-5834, 1999
37. RUPEREZ M, RUIZ-URTEGA M, ESTEBAN V, et al: Angiotensin II increases connective tissue growth factor in the kidney. Am J Pathol 163:1937-1947, 2003
38. KEIL A, BLOM IE, GOLDSCHMEDING R, et al: Nitric oxide downregulates connective tissue growth factor in rat mesangial cells. Kidney Int 62:401-411, 2002
39. SCHAEFFER HJ, WEBER MJ: Mitogen-activated protein kinases: Specific messages from ubiquitous messengers. Mol Cell Biol 19:2435-2444, 1999
40. WETZKER R, BOHMER FD: Transactivation joins multiple tracks to the ERK/MAPK cascade. Nat Mol Cell Biol 4:651-657, 2003
41. KYRIAKIS JM, AVRUCH J: Mammalian MAPK signal transduction pathways activated by stress and inflammation. Physiol Rev 81:807-869, 2001
42. UTSUGI M, DOBASHI K, ISHIZUKA T, et al: C-Jun-NH2-terminal kinase mediates expression of connective tissue growth factor induced by transforming growth factor-β in human lung fibroblasts. Am J Res Cell Mol Biol 28:754-761, 2003
43. CHIN BY, MOHSENIN A, LI SX, et al: Stimulation of pro-alpha I collagen by TGF-beta in mesangial cells: Role of the p38 MAPK pathway. Am J Physiol 28:F495-F504, 2001
44. ISONO M, CRUZ C, CHEN S, et al: Extracellular signal-regulated kinase mediates stimulation of TGF-β and matrix by high glucose in mesangial cells. J Am Soc Nephrol 11:2222-2230, 2000
45. KARIN M, LIU Z, ZANDI E: AP-1 function and regulation. Curr Opin Cell Biol 9:240-246, 1997
46. KIM S, ANGEL P, LAFYATIS R, et al: Autoinduction of transforming growth factor β is mediated by the AP-1 complex. Mol Cell Biol 10:1492-1497, 1990
47. CHEN Y, BLOM IE, SA S, et al: CTGF expression in mesangial cells: Involvement of SMADs, M AP kinase and PKC. Kidney Int 62:1149-1159, 2002
48. LEASK A, HOLMES A, BLACK CM, et al: Connective tissue growth factor gene regulation. J Biol Chem 278:13008-13015, 2003